Lv3
364 积分 2021-01-13 加入
Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas
4个月前
已完结
Sequential antigen loss and branching evolution in lymphoma after CD19- and CD20-targeted T-cell–redirecting therapy
4个月前
已完结
CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS
4个月前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
4个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
4个月前
已完结
Successful 24-Hours Manufacture of Anti-CD19/CD22 Dual Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia (B-ALL)
4个月前
已完结
Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemia
5个月前
已完结
Preparation and characterization of a chimeric CD 19 monoclonal antibody
5个月前
已完结
皖公网安备34019202002308
